HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Echinocandins: a wealth of choice--how clinically different are they?

AbstractPURPOSE OF REVIEW:
The recent decade has been a 'golden age' for antifungal therapy. The introduction of a novel class of antifungals, the echinocandins, has revolutionized the therapy for invasive candidiasis, provided increasing options for antifungal prophylaxis in high-risk patients and energized the debate regarding combination antifungal therapy for invasive mycoses.
RECENT FINDINGS:
Randomized, controlled data exist for each echinocandin in the treatment of invasive candidiasis, and experts largely believe the agents to be equivalent in this setting. Future trials of combined echinocandin-triazole therapy for invasive aspergillosis are desired. Additionally, maximal dosing limitations are being pursued.
SUMMARY:
The echinocandins as a class offer an advance in the treatment of invasive candidiasis, an additional option for prophylaxis and an attractive choice for the study of combination antifungal therapy. Particularly for the major indication (treatment of invasive candidiasis), major clinical differences between agents have not been noted.
AuthorsAimee K Zaas
JournalCurrent opinion in infectious diseases (Curr Opin Infect Dis) Vol. 21 Issue 4 Pg. 426-32 (Aug 2008) ISSN: 1473-6527 [Electronic] United States
PMID18594297 (Publication Type: Journal Article, Review)
Chemical References
  • Antifungal Agents
  • Echinocandins
  • Triazoles
Topics
  • Antifungal Agents (pharmacology, therapeutic use)
  • Aspergillosis (drug therapy)
  • Candidiasis (drug therapy, prevention & control)
  • Chemoprevention
  • Drug Therapy, Combination
  • Echinocandins (pharmacology, therapeutic use)
  • Fungi (drug effects)
  • Humans
  • Triazoles (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: